RecallDepth
Class II Ongoing

Valsartan Tablets USP 80 mg, 90 count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., Dayton, NJ --- NDC 65862-571-90

Company
Aurobindo Pharma Usa Inc.
Recall Initiated
December 31, 2018
Posted
March 27, 2019
Recall Number
D-1038-2019
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
East Windsor, NJ, United States

Reason for Recall

GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.

Distribution

Product was distributed to major distribution chains throughout the United States.

Lot / Code Info

Lot Numbers: 471170015A, exp. date Sep 2019; 471180004A, 471180005A, exp. date Feb 2019

More recalls by Aurobindo Pharma Usa Inc.

View all recalls by this company →

Other recent Class II Drug recalls